Myeloma Minute: October 8, 2015
In the News: Myeloma Debates, Drug Costs, Reading that Matters
In his blog this week, IMF Chairman Dr. Brian Durie recaps the International Myeloma Workshop (IMW) meeting in Rome, where myeloma experts debated, among other questions, whether we are curing myeloma. He also comments on recent news articles investigating the rise of drug prices, the value of calcium supplements, and if tea is as good for you as coffee. And finally, he connects the dots between antimatter and PET scans. To read Dr. Durie’s blog, click HERE.
There's Still Time to Be Part of the IMF's 9th Annual Comedy Celebration on Saturday
There are still two days left to purchase tickets to this Saturday’s 9th Annual Comedy Celebration gala, featuring talented comics Jeff Garlin, Tig Notaro, Fred Willard, Heather McDonald, and musical guest Paul Shaffer. Watch the event’s host, Fred Willard, talk about the event on “Good Day LA.” Proceeds from the event benefit the Peter Boyle Research Fund, as well as support the Black Swan Research Initiative®, the IMF's collaborative project aimed at developing the first definitive cure for myeloma. The night kicks off at 6 pm at the Wilshire Ebell Theatre & Club in Los Angeles and you can purchase tickets HERE.
Clinical Trial to Assess Efficacy of Once-Weekly Dosing for Kyprolis
Onyx/Amgen is conducting the randomized, phase III ARROW clinical trial to potentially provide patients and physicians with a more convenient once-weekly dosing schedule for Kyprolis (carfilzomib). Currently, Kyprolis is administered by IV infusion twice weekly. Patients will randomly be assigned to receive Kyprolis either once or twice a week along with weekly dexamethasone. The ARROW trial is for patients with relapsed and refractory myeloma who have previously been treated with VelcadeR and one of the immunomodulatory drugs: ThalomidR, RevlimidR, or PomalystR. For more information, read our ARROW Clinical Trial Fact Sheet HERE.
Register Now for the Next Living Well with Myeloma Teleconference on November 19
The next teleconference in the Living Well with Myeloma series will be on Thursday, November 19. IMF Chairman Dr. Brian Durie will present “Myeloma 101: Updates on Treatment & Pain Management” during this informative teleconference, and will shed light on the most up-to-date therapies for myeloma patients. The 60-minute teleconference begins at 4 pm PT/7 pm ET and is not to be missed! To register, please click HERE.